Zobrazeno 1 - 10
of 525
pro vyhledávání: '"S Verbeke"'
Autor:
Yuchuan Li, Manoj Amrutkar, Anette Vefferstad Finstadsveen, Knut Tomas Dalen, Caroline S. Verbeke, Ivar P. Gladhaug
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-20 (2023)
Abstract Background Despite therapeutic advances, the prognosis of pancreatic ductal adenocarcinoma (PDAC) remains extremely poor. Metabolic reprogramming is increasingly recognized as a key contributor to tumor progression and therapy resistance in
Externí odkaz:
https://doaj.org/article/74434962bd09482d846da247de4e9099
Autor:
Manoj Amrutkar, Kjersti Berg, Aina Balto, Miguel G. Skilbrei, Anette V. Finstadsveen, Monica Aasrum, Ivar P. Gladhaug, Caroline S. Verbeke
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-17 (2023)
Abstract Background Profound resistance to chemotherapy remains a major challenge in achieving better clinical outcomes for patients with pancreatic ductal adenocarcinoma (PDAC). Recent studies indicate that gemcitabine (GEM) resistance is promoted b
Externí odkaz:
https://doaj.org/article/0a8551fe28fd4ded98dac870dafde5e6
Autor:
Manoj Amrutkar, Caroline S. Verbeke, Anette Vefferstad Finstadsveen, Linda Dorg, Knut Jørgen Labori, Ivar P. Gladhaug
Publikováno v:
Molecular Oncology, Vol 17, Iss 1, Pp 59-81 (2023)
The modest clinical benefits of neoadjuvant chemotherapy (NAT) in pancreatic ductal adenocarcinoma (PDAC) are associated with a lack of robust data on treatment‐induced changes in the tumor. To this end, comparative proteomic profiling of tumor tis
Externí odkaz:
https://doaj.org/article/fe5b77bf594f407d93f1ecf9688ee52d
Autor:
S. Verbeke, R. Perret, V. Chaire, E. Richard, V. Velasco, F. Giles, L. Cavalcante, A. Italiano
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-5 (2021)
Abstract Soft tissue sarcoma (STS) is a predominantly fatal rare malignancy with inadequate treatment options. Glycogen synthase kinase 3β (GSK-3β) is an emerging target in human malignancies. Its therapeutic relevance in STS is unknown. We analyze
Externí odkaz:
https://doaj.org/article/cbb98c95e2e745d88a7d6d2402a0a230
Autor:
J.-M. Lohr, U. Beuers, M. Vujasinovic, D. Alvaro, J. B. Frøkjær, F. Buttgereit, G. Capurso, E. L. Culver, E. de-Madaria, E. Della-Torre, S. Detlefsen, E. Dominguez-Munoz, P. Czubkowski, N. Ewald, L. Frulloni, N. Gubergrits, D. G. Duman, Th. Hackert, J. Iglesias-Garcia, N. Kartalis, A. Laghi, F. Lammert, F. Lindgren, A. Okhlobystin, G. Oracz, A. Parniczky, R. M. P. Mucelli, V. Rebours, J. Rosendahl, N. Schleinitz, A. Schneider, E. FH van Bommel, C. S. Verbeke, M. P. Vullierme, H. Witt, the UEG guideline working group
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 31, Iss 1, Pp 80-114 (2021)
The overall objective of these guidelines is to provide evidence-based recommendations for the diagnosis and management of immunoglobulin G4 (IgG4)-related digestive disease in adults and children. IgG4-related digestive disease can be diagnosed only
Externí odkaz:
https://doaj.org/article/a041ede29ff947239e20fb7d20b7781d
Autor:
Hua Wang, Alexander J. Najibi, Miguel C. Sobral, Bo Ri Seo, Jun Yong Lee, David Wu, Aileen Weiwei Li, Catia S. Verbeke, David J. Mooney
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
The immunosuppressive tumour microenvironment impairs immunotherapy in poorly immunogenic cancer. Here, the authors load an alginate gel with GM-CSF, CpG oligonucleotides and doxorubicin-iRGD to promote immunogenic death of tumour cells and improve i
Externí odkaz:
https://doaj.org/article/2af10e759cc3482da0ca26d55a1844d7
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-16 (2019)
Abstract Background Gemcitabine remains a cornerstone in chemotherapy of pancreatic ductal adenocarcinoma (PDAC) despite suboptimal clinical effects that are partly due to the development of chemoresistance. Pancreatic stellate cells (PSCs) of the tu
Externí odkaz:
https://doaj.org/article/c056b0f49e6d4e2ba4b1c4847316ec3b
Autor:
P.A. Sutera, A.C. Shetty, A. Hakansson, K. Van der Eecken, Y. Song, Y. Liu, J. Chang, V. Fonteyne, A.A. Mendes, N. Lumen, L. Delrue, S. Verbeke, K. De Man, Z. Rana, T. Hodges, A. Hamid, N. Roberts, D.Y. Song, K. Pienta, A.E. Ross, F. Feng, S. Joniau, D. Spratt, S. Gillessen, G. Attard, N.D. James, T. Lotan, E. Davicioni, C. Sweeney, P.T. Tran, M.P. Deek, P. Ost
Publikováno v:
Annals of Oncology.
Autor:
Manoj Amrutkar, Emma Kristine Larsen, Monica Aasrum, Anette Vefferstad Finstadsveen, Per Arne Andresen, Caroline S. Verbeke, Ivar P. Gladhaug
Publikováno v:
Cells, Vol 9, Iss 1, p 227 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is characterized by an extremely poor prognosis, and its treatment remains a challenge. As the existing in vitro experimental models offer only a limited resemblance to human PDAC, there is a strong need for ad
Externí odkaz:
https://doaj.org/article/e017ea439478445bb8d912819d80296a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.